Caplin Point Laboratories

BSE : 524742 | NSE : CAPLIPOINT

Industry : Pharma Formulations | ISIN : INE475E01026 | FreeFloat : 24.27% | FnO : No | LotSize : N/A


Intellectual Capital (IC)3,825.53
Net Worth (NW)1,713.41
Intrinsic Worth (IW)5,538.94
Market Cap (MC)5,642.59
Economic Value Added24.29
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)69.07%
IC Gross Margin (EBITDA/IC)13.04%
IC Net Margin (NPT/IC)10.90%
Knowledge Turnover (Sales/IC)0.38
Market to Intrinsic Value (MC/IW)1.02

As OfIntrinsic ValueMarket Price
30 Sep 2022Rs. 730.73Rs. 744.40
3 Feb 2023 ---- Rs. 693.40
-5.75     -0.83%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 690.91ReduceBuy on Dips
KB > 50% : Yes50 DMA : Rs. 721.75
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-19
C
228.21
238.55
78.11
69.68
69.62
58.84
60.10
Mar-20
C
215.23
234.87
73.44
65.03
64.87
48.86
60.18
Jun-20
C
240.08
246.57
78.09
69.13
68.62
54.55
54.54
Sep-20
C
268.12
269.88
89.19
80.31
79.83
62.83
56.21
Dec-20
C
274.39
280.21
89.75
80.48
80.20
66.14
62.78
Mar-21
C
278.71
288.17
95.15
85.29
84.97
67.92
70.43
Jun-21
C
300.44
309.65
101.82
89.79
89.52
71.53
76.47
Sep-21
C
303.53
312.02
109.66
97.94
97.73
76.82
76.82
Dec-21
C
326.20
335.74
110.50
98.80
98.66
79.28
79.21
Mar-22
C
339.24
350.75
111.45
100.00
99.92
80.83
91.43
Jun-22
C
346.33
360.27
116.12
105.15
105.09
86.31
108.37
Sep-22
C
359.05
375.53
122.05
110.59
110.45
92.03
107.72
* C - Consolidated, S - Standalone